Clinical efficacy: where CT-388 stands K-Dense Web curated placebo-controlled weight loss data from peer-reviewed publications (STEP 1-4, SURMOUNT-1-4, retatrutide Phase 2, CT-388 Phase 2) and applied a critical methodological filter: only Standard-design, Non-T2D trials were used for cross-drug comparisons
GLP-1 receptor agonists mimic GLP-1, lowering blood glucose by stimulating insulin secretion, slowing gastric emptying, and decreasing glucagon release 13
Monitor Progress, Adjust, and Stay Accountable Over Time Successful GLP-1 therapy requires consistent monitoring of weight, energy levels, appetite, digestion, and overall well-being
Cost Comparison 2026 Out-of-pocket costs for both medications can vary widely depending on insurance coverage and available discount programs